Financhill
Back

LendingTree Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
34

TREE
LendingTree

Last Price:
39.80
Seasonality Move:
11.4%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
34
LendingTree (TREE) is a Sell

Is LendingTree a Buy, Sell or Hold?

  • The current LendingTree [TREE] share price is $39.78. The Score for TREE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • TREE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TREE Stock Price Chart

What is LendingTree's stock price today?

  • The LendingTree share price today is $39.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TREE is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

TREE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.68 Sell
Relative Strength Index (14 RSI): 41.15 Sell
Chaikin Money Flow: -21163 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.63 - 45.21) Sell
Bollinger Bands (100): (35.3 - 44.94) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

TREE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.43 Sell
20-day SMA: 42.98 Sell
50-day SMA: 42.71 Sell
200-day SMA: 30.08 Buy
8-day EMA: 41.8 Sell
20-day EMA: 42.79 Sell
50-day EMA: 42.38 Sell
200-day EMA: 34.93 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

LendingTree Earnings Growth & TREE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.35 per share, an increase this year of $0.50 per share, and an increase next year of $0.75 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

LendingTree Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):